Suchergebnisse - "Salwender, Hans"

PubPharm (164)

1

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients

enthalten in: Leukemia | 2024

von Mai, E. | Hielscher, T. | Bertsch, U. | +26

2

Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany

enthalten in: Bone marrow transplantation | 2024

von Sauer, S. | Engelhardt, M. | Trautmann-Grill, K. | +11

3

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The lancet / Haematology | February 2024

von Mai, E. | Goldschmidt, H. | Miah, K. | +32

4

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Leypoldt, L. | Tichy, D. | Besemer, B. | +24

5

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Mai, E. | Goldschmid, H. | Miah, K. | +74

ErratumIn: Lancet Haematol. 2024 Feb 7;:. - PMID 38340740

6

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von Salwender, H. | Weinhold, N. | Benner, A. | +23

7

Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients less than 60 years of age : a prospective phase II study

enthalten in: Haematologica | 2023

von Kröger, N. | Wulf, G. | Hegenbart, U. | +26

8

Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment : Results from the Phase 2 GMMG-DANTE Trial

enthalten in: Cancers | 2023

von Leypoldt, L. | Gavriatopoulou, M. | Besemer, B. | +12

9

Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma

enthalten in: The FEBS journal | 2023

von Berghaus, N. | Schreiner, S. | Poos, A. | +11

10

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma : final analysis of PLEIADES and EQUULEUS

enthalten in: Blood cancer journal | 2023

von Moreau, P. | Chari, A. | Oriol, A. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]